Your browser doesn't support javascript.
loading
Time dependent analysis of assay comparability: a novel approach to understand intra- and inter-site variability over time.
Winiwarter, Susanne; Middleton, Brian; Jones, Barry; Courtney, Paul; Lindmark, Bo; Page, Ken M; Clark, Alan; Landqvist, Claire.
Afiliação
  • Winiwarter S; Innovative Medicines, Drug Safety and Metabolism, AstraZeneca R&D Mölndal, Pepparedsleden 1, 431 83, Mölndal, Sweden. susanne.winiwarter@astrazeneca.com.
  • Middleton B; Innovative Medicines, Discovery Sciences, AstraZeneca R&D Alderley Park, Macclesfield, Cheshire, SK10 4TF, UK.
  • Jones B; Innovative Medicines, Drug Safety and Metabolism, AstraZeneca R&D Cambridge, Unit 310 - Darwin Building, Cambridge Science Park, Milton Road, Cambridge, CB4 0WG, UK.
  • Courtney P; Global Medicines Development, Pharmaceutical Development, AstraZeneca R&D, Charter Way, Silk Road Business Park, Macclesfield, Cheshire, SK10 2NA, UK.
  • Lindmark B; Innovative Medicines, Cardiovascular and Metabolic Diseases, AstraZeneca R&D Mölndal, Pepparedsleden 1, 43183, Mölndal, Sweden.
  • Page KM; Innovative Medicines, Drug Safety and Metabolism, AstraZeneca R&D Alderley Park, Macclesfield, Cheshire, SK10 4TF, UK.
  • Clark A; Innovative Medicines, Drug Safety and Metabolism, AstraZeneca R&D Boston, 35 Gatehouse Park, Waltham, MA, 01742, USA.
  • Landqvist C; Innovative Medicines, Drug Safety and Metabolism, AstraZeneca R&D Mölndal, Pepparedsleden 1, 431 83, Mölndal, Sweden.
J Comput Aided Mol Des ; 29(9): 795-807, 2015 Sep.
Article em En | MEDLINE | ID: mdl-25697964
ABSTRACT
We demonstrate here a novel use of statistical tools to study intra- and inter-site assay variability of five early drug metabolism and pharmacokinetics in vitro assays over time. Firstly, a tool for process control is presented. It shows the overall assay variability but allows also the following of changes due to assay adjustments and can additionally highlight other, potentially unexpected variations. Secondly, we define the minimum discriminatory difference/ratio to support projects to understand how experimental values measured at different sites at a given time can be compared. Such discriminatory values are calculated for 3 month periods and followed over time for each assay. Again assay modifications, especially assay harmonization efforts, can be noted. Both the process control tool and the variability estimates are based on the results of control compounds tested every time an assay is run. Variability estimates for a limited set of project compounds were computed as well and found to be comparable. This analysis reinforces the need to consider assay variability in decision making, compound ranking and in silico modeling.
Assuntos
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Farmacocinética / Interpretação Estatística de Dados / Ensaios de Triagem em Larga Escala Tipo de estudo: Prognostic_studies Limite: Animals / Humans Idioma: En Revista: J Comput Aided Mol Des Assunto da revista: BIOLOGIA MOLECULAR / ENGENHARIA BIOMEDICA Ano de publicação: 2015 Tipo de documento: Article País de afiliação: Suécia

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Farmacocinética / Interpretação Estatística de Dados / Ensaios de Triagem em Larga Escala Tipo de estudo: Prognostic_studies Limite: Animals / Humans Idioma: En Revista: J Comput Aided Mol Des Assunto da revista: BIOLOGIA MOLECULAR / ENGENHARIA BIOMEDICA Ano de publicação: 2015 Tipo de documento: Article País de afiliação: Suécia